Rising cloud storage costs, data lock-in and frequent outages are driving interest in decentralized alternatives, according ...

Aperture Therapeutics, a biotechnology company pioneering next-generation precision medicines for neurodegenerative diseases, today announced the advancement of its matrix metalloproteinase-9 (MMP9) ...